DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency
Thomas Köhnke, Daiki Karigane, Eleanor Hilgart, Amy C. Fan, Kensuke Kayamori, Masashi Miyauchi, Cailin T. Collins, Fabian Patrik Suchy, Athreya S Rangavajhula, Yang Feng, Yusuke Nakauchi, Eduardo Martinez-Montes, Jonas L. Fowler, Kyle M. Loh, Hiromitsu Nakauchi, , Ravindra Majeti
This study shows DNMT3AR882H mutations are not required for maintaining AML but are linked to higher leukemia stem cell frequency.
Cancer Discovery · Nov 20, 2025Peer-reviewedCancer Biology